TSCO:LSETesco PLC Analysis
Data as of 2026-07-06 - not real-time
£459.10
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Tesco shares are trading near the 20‑day SMA (≈459.3) and just below the 50‑day SMA, with a neutral price trend but a bullish MACD histogram (+1.39) suggesting short‑term momentum may turn positive. The stock trades at a forward P/E of ~13.7, well below the historical average, and the DCF‑derived fair value of £470.7 indicates roughly 12% upside to current levels. A dividend yield of 3.11% backed by a 52% payout ratio and solid free cash flow supports the case for income‑focused investors. Recent analyst commentary highlights Tesco’s “ecosystem” strategy and resilience against rivals, while the upcoming Q1 earnings update is expected to reassure investors despite modest sales‑growth moderation.
The defensive grocery sector, low beta (≈0.0) and a strong balance sheet with £4.2bn cash offsetting a high debt load, combine with an “Extreme Greed” market sentiment to create a compelling buying window, though the 30‑day volatility of 26% and a recent decline in volume advise caution on position sizing.
The defensive grocery sector, low beta (≈0.0) and a strong balance sheet with £4.2bn cash offsetting a high debt load, combine with an “Extreme Greed” market sentiment to create a compelling buying window, though the 30‑day volatility of 26% and a recent decline in volume advise caution on position sizing.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram indicating momentum shift
- Undervaluation relative to DCF fair value
- Upcoming earnings update as catalyst
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Analyst price targets around £515‑£560
- Sustainable dividend yield above 3%
- Ecosystem strategy enhancing market share
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Stable cash flow and defensive sector positioning
- High debt‑to‑equity ratio requiring monitoring
- Long‑term dividend income and modest growth outlook
Key Metrics & Analysis
Financial Health
Revenue Growth7.20%
Profit Margin2.42%
P/E Ratio17.0
ROE15.46%
ROA4.93%
Debt/Equity131.62
P/B Ratio2.5
Op. Cash Flow£3.9B
Free Cash Flow£2.2B
Technical Analysis
TrendNeutral
RSI50.3
Support£436.30
Resistance£510.40
MA 20£459.31
MA 50£459.89
MA 200£456.54
MACDBullish
VolumeDecreasing
Fear & Greed Index93.52
Valuation
Fair Value£470.70
Target Price£513.67
Upside/Downside11.89%
GradeUndervalued
TypeBlend
Dividend Yield3.11%
Risk Assessment
Beta-0.10
Volatility26.23%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.